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Proliferative responses of mice to a cloned Plasmodium Falciparum Sporozoite antigen A peptide fragment of the L £anga circumsporozoite protein (CSP) containing 30 repeats of the immunodominant ASN-ALA-ASN-PRO and two of the VAL ASP variants (R32tet32) is currently being evaluated as a vaccine in man. This R32tet32 peptideo prepared by recombinant DNA technology from a cloned 2. fa gene fragmeni;, has been examined for its ability to stimulate T-cell proliferation in experimental animals. Groups of mice were injected with either R32tet32 emulsified in Freund's complete adjuvant (CFA), or live, or frozen-thawed R. falca= sporozoites + CFA. Lymphocytes from such mice were co-cultured with varying doses of R32tet32 or irrelevant antigen. Proliferation was assessed by 39-thymidine uptake; serum antibody was analyzed by ELISA. A proliferative response was found in mice immunized with R32tet32 F CFA as early as day 7 post-injection, and was persistent through at least day 23. No proliferation in response to R32tet32 was observed in lymphocytes taken from mice injected with live or frozen-thawed sporozoites. The amino add sequence contains a repeated tetrapeptide unit fused with 32 amino acids encoded by a tetracycline-resistance gene read out of frame, and is named R32tet32. Recent studies suggest that the authentic malaria peptide may contain epitopes that are not present in the R32tet32 construct (6). Such information suggests that the R32tet32 peptide may be insufficient to generate an effective T-cell memory response which could be necessary in effective vaccination. Recent results with cholera toxin (7) have demonstrated that certain synthetic peptides are able to prime rabbits to respond to booster inoculation of toxin with a strong neutralizing antibody response, but not to induce neutralizing antibody after primary inoculation alone.
PERSONAL AUTPOR(S)
These results suggest an additional approach for the testing of cloned peptides as vaccines. The objective of the studies reported in this paper is to investigate the immunogenic properties of both the R32tet32 peptide and whole P falcigarum spz in mice.
MATERIALS AND METHODS
Mice. BALB/cByJ female mice were obtained from the Jackson Laboratory, Bar
Harbor, ME, and housed in laminar flow facilities until used in the experiments presented here.
Antigen. a peptide fragment of the P. fiarum circumsporozoite protein ( 
RESULTS
Proliferative responses. In Table I , it can be seen that inguinal and sciatic LNC from mice primed with 20 ug R32tet32 + CFA were able to proliferate in Ytm when restimulaed with the homologous antigen. LNC taken from mice injected with 30,000 E. huLom spz + CFA or injected with adjuvant alone (CFA) did not proliferate.
These data show that the cloned polypeptide chain is capable of stimulating T-cell immunity when injected into mice. LNC taken from mice injected with 30,000
frozen-thawed E. faidpgrum spz and restimulated in AMr with R32tet32 were not able to proliferate. These data suggest that, even though the R32 peptide is contained in the P_. IaIaMjM sporozoite, it may not be recognized by T cells immune to spz in such a way as to generate a proliferative response to the cloned peptide, or that the dose of 30,000 spz is insufficient.
The data shown in Figure 1 indicate that the proliferative response can be
Additional data (not shown) indicate that in vivo immunization with R32tet32 elicits a long-lasting proliferation response which persists until at least day 23 post-injection.
The data presented in Table II show that proliferation of immune LNC can be reduced by treatment n yitr with monoclonal anti-Thy 1.2 + C. That the control proliferation in response to Con A is reduced but not eliminated suggests that not all T cells were eliminated with one cycle of antibody and C treatment. Again, LNC taken from mice injected with adjuvant alone did not proliferate in response to the R32tet32 peptide.
Antibody responses. The data in Figure 2 show that mice injected with either the cloned R32tet32 + CFA peptide or P. falciparum spz + CFA developed antibody to the R32tet32 peptlde. This is in contrast to the data presented above, in which mice injected with spz did not develop a proliferative response to R32tet32. The data presented in Figure 2 were developed using a secondary reagent which recognizes IgM and IgG; similar results were obtained when using secondary reagents directed to either mouse IgM or mouse IgG (data not shown). These results suggest that the dose used in the CSP antigen present on the spz is capable of stimulating an antibody response to R32tet32, but cannot stimulate a proliferative response to the peptide produced by recombinant means.
DISCUSSION
The role of T cells in resistance to malaria in both humans and experimental an:. ials has been the subject of intense study. Current theories support a helper role 
